美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

生物科技指數ETF-iShares Nasdaq

203.49

+1.490.74%

成交量：41.74萬

成交額：8,471.28萬

市值：103.68億

市盈率：32.24

高：204.16

開：202.49

低：202.07

收：202.00

52周最高：217.12

52周最低：138.79

股本：5,095.00萬

流通股本：5,095.00萬

量比：0.49

換手率：0.82%

股息：0.40

股息率：0.20%

每股收益(TTM):6.31

每股收益(LYR):35.34

淨資產收益率：24.54%

總資產收益率：0.10%

市淨率：1.27

市盈率(LYR):5.76

資料載入中...

總覽公司新聞資訊公告

AbCellera Biologics獲2800萬美元預付款及里程碑付款與階梯式版税

AbCellera攜手福泰製藥，共同開發針對自身免疫疾病的多特異性T細胞接合器

安進(AMGN)股票7月28日盤中上漲4.02%：背後推手曝光

TradingKey中文

解讀世界500強排行榜醫藥板塊：強生繼續「霸榜」，禮來排名上升112位，3家中國企業入選

每日经济新闻

Bitget 已上線 SKDD、GILD、TMF 等 9 只股票永續合約

安進提交新數據，對美國食品藥品監督管理局（FDA）關於撤回Tavneos的提議提出異議

吉利德科學(GILD)腫瘤組合療法獲歐洲藥品管理局旗下CHMP推薦

CHMP推薦吉利德Trodelvy®聯合Keytruda®用於PD-(L)1陽性一線轉移性三陰性乳腺癌

百濟神州/安進 FIC 雙抗，皮下製劑進入 III 期

argenx(ARGX)二季度產品淨銷售額達15.16億美元按年增長60%

美國研究綜述-Alphabet、IBM、特斯拉

數據簡報-邦迪布吉奧埃博拉病毒：正在研發哪些疫苗和治療方法

創新藥研發加速遇「猴荒」

吉利德與默克聯合研發的每周服用一次的艾滋病口服藥在晚期臨床試驗中成功抑制了病毒

安進就股東提起的指控其隱瞞107億美元税單的訴訟達成和解

Leerink Partners下調吉利德科學評級至「與大盤持平」，目標價大幅調降至127美元

Leerink下調吉利德科學目標價至127美元

Kalshi將允許對臨床試驗和FDA決定進行投注

三星生物製劑與歐加農將在澳大利亞推出新型生物類似藥。

剛果啓動吉利德實驗性抗病毒藥物邦迪布吉奧埃博拉病毒試驗

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hant/stock/IBB/news?page=9"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IBB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBB\",,,,,undefined,":{"symbol":"IBB","market":"US","secType":"STK","nameCN":"生物科技指數ETF-iShares Nasdaq","latestPrice":203.49,"timestamp":1789577103862,"preClose":202,"halted":0,"volume":417353,"delay":0,"changeRate":0.007376237623762421,"floatShares":50950000,"shares":50950000,"eps":6.311863,"marketStatus":"交易中","change":1.49,"latestTime":"09-16 12:45:07 EDT","open":202.49,"high":204.1599,"low":202.07,"amount":84712813.64273,"amplitude":0.010346,"askPrice":203.53,"askSize":26,"bidPrice":203.49,"bidSize":144,"shortable":3,"etf":1,"ttmEps":6.311863,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1789588800000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":202,"sharesOutstanding":49450000,"nav":204.610559,"aum":10516982732.6,"dividendRate":0.001985,"bidAskSpread":0.000306,"preHourTrading":{"tag":"盘前","latestPrice":203.71,"preClose":202,"latestTime":"09:17 EDT","volume":108,"amount":21996.522,"timestamp":1789564649878,"change":1.71,"changeRate":0.008465,"amplitude":0.010149},"postHourTrading":{"tag":"盘后","latestPrice":203.09,"preClose":202,"latestTime":"19:59 EDT","volume":3436,"amount":694324.56,"timestamp":1789516769053,"change":1.09,"changeRate":0.005396,"amplitude":0.005396},"volumeRatio":0.486031,"impliedVol":0.2208,"impliedVolPercentile":0.3147},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBB\",,,,,undefined,":{"symbol":"IBB","floatShares":50950000,"roa":"0.10%","roe":"24.54%","lyrEps":35.344796,"volumeRatio":0.486031,"shares":50950000,"dividePrice":0.404,"high":204.1599,"amplitude":0.010346,"preClose":202,"low":202.07,"week52Low":138.785,"pbRate":"1.27","psRate":"249.44","week52High":217.12,"institutionHeld":0,"latestPrice":203.49,"committee":0.694118,"eps":6.311863,"divideRate":0.001985,"volume":417353,"delay":0,"ttmEps":6.311863,"open":202.49,"prevYearClose":168.77,"prevWeekClose":202.93,"prevMonthClose":209.05,"prevQuarterClose":190.19,"fiveDayClose":205.49,"twentyDayClose":203.56,"sixtyDayClose":177},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IBB\",params:#limit:5,,,undefined,":[{"date":"2026-09-15","symbol":"IBB","amount":0.011194,"announcedDate":"2026-09-14","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-15","defaultRemindTime":1789479000000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-18","payableDate":"2026-09-15","currency":"USD","dateTimestamp":1789444800000,"payDate":"2026-09-18"},{"date":"2026-06-15","symbol":"IBB","amount":0.023774,"announcedDate":"2026-06-12","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-15","defaultRemindTime":1781530200000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-18","payableDate":"2026-06-15","currency":"USD","dateTimestamp":1781496000000,"payDate":"2026-06-18"},{"date":"2026-03-17","symbol":"IBB","amount":0.121818,"announcedDate":"2026-03-16","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-17","defaultRemindTime":1773754200000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-20","payableDate":"2026-03-17","currency":"USD","dateTimestamp":1773720000000,"payDate":"2026-03-20"},{"date":"2025-12-16","symbol":"IBB","amount":0.183099,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-19","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-19"},{"date":"2025-09-16","symbol":"IBB","amount":0.082843,"announcedDate":"2025-09-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-16","defaultRemindTime":1758029400000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-19","payableDate":"2025-09-16","currency":"USD","dateTimestamp":1757995200000,"payDate":"2025-09-19"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IBB\",market:\"US\",,,undefined,":[{"executeDate":"2016-09-26","recordDate":"2016-09-28","paymentDate":"2016-09-30","value":0.0858219,"currency":"USD"},{"executeDate":"2016-12-22","recordDate":"2016-12-27","paymentDate":"2016-12-29","value":0.091903,"currency":"USD"},{"executeDate":"2017-03-24","recordDate":"2017-03-28","paymentDate":"2017-03-30","value":0.29898,"currency":"USD"},{"executeDate":"2017-06-27","recordDate":"2017-06-29","paymentDate":"2017-06-30","value":0.176803,"currency":"USD"},{"executeDate":"2017-09-26","recordDate":"2017-09-27","paymentDate":"2017-09-29","value":0.118654,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IBB\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IBB\",pageSize:20,pageCount:9,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1185330982","title":"AbCellera Biologics獲2800萬美元預付款及里程碑付款與階梯式版税","url":"https://stock-news.laohu8.com/highlight/detail?id=1185330982","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185330982?lang=zh_tw&edition=fundamental","pubTime":"2026-07-29 19:06","pubTimestamp":1785323188,"startTime":"0","endTime":"0","summary":"AbCellera Biologics公司宣布，将收到一笔高达2800万美元的预付款。除此之外，还有里程碑付款以及阶梯式特许权使用费加持。这笔交易架构颇为复杂，既有前期现金注入，也有后续潜在收益。预付款即刻到账，为研发管线提供弹药。里程碑款项则与特定项目进展挂钩，分期兑现。至于阶梯式版税，会随着产品销售额的攀升而逐步增加。整体来看，这一支付安排既保障了短期资金流，又锁定了长期回报空间。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0109394709.USD","LU0058720904.USD","LU2462157665.USD","LU2362541273.HKD","SG9999001176.SGD","IBB","VRTX","LU2324357040.USD","BK4567","LU0061475181.USD","LU2456880835.USD","SG9999001176.USD","BK4139","IE00B19Z3581.USD","BK4533","BK4532","LU0320765992.SGD","LU1035775433.USD","LU1093756325.SGD","PBE","BK4535","IE00B19Z3B42.SGD","LU0889565916.HKD","ABCL","BIB","LU2236285917.USD","LU0432979614.USD","BK4121","IE00BZ9MQY76.HKD","LU1674673691.USD","LU1674673428.USD","TBXU","LU2362540622.SGD","LU2237438978.USD","LU0256863811.USD","LU0823416689.USD","IE0002270589.USD","LU0289739699.SGD","LU1069344957.HKD","LU1093756168.USD","LU1778281490.HKD","IE00B19Z9Z06.USD","IE00B4R5TH58.HKD","BK4585","IE00B894F039.SGD","IE00BFTCPJ56.SGD","LU0079474960.USD","IBBQ","BBH","BK4588","LU0417517546.SGD","LU1430594728.SGD","LU1585245621.USD","GNMX","LU2362541513.USD","IE0009355771.USD","LU2417539215.USD","SG9999013999.USD","IE00BJT1NW94.SGD","LU0234570918.USD","IE00B19Z9P08.USD","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","SGXZ57979304.SGD","IDNA","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147206442","title":"AbCellera攜手福泰製藥，共同開發針對自身免疫疾病的多特異性T細胞接合器","url":"https://stock-news.laohu8.com/highlight/detail?id=1147206442","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1147206442?lang=zh_tw&edition=fundamental","pubTime":"2026-07-29 19:01","pubTimestamp":1785322903,"startTime":"0","endTime":"0","summary":"AbCellera宣布与福泰制药达成合作，旨在共同探索和发现针对自身免疫性疾病及其他适应症的多特异性T细胞接合器。这一战略合作将结合双方的技术优势，致力于在治疗领域开拓创新路径。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBH","IBB","LU0889565916.HKD","LU1093756325.SGD","BK4533","IE0009355771.USD","BK4535","IE00BZ9MQY76.HKD","LU1778281490.HKD","LU2362541273.HKD","SG9999001176.USD","IE00BJT1NW94.SGD","TBXU","LU2456880835.USD","PBE","BK4567","LU0061475181.USD","BK4139","IE00BFTCPJ56.SGD","LU2362540622.SGD","ABCL","GNMX","LU1430594728.SGD","LU0079474960.USD","LU0234570918.USD","LU1585245621.USD","LU2362541513.USD","SG9999013999.USD","BK4585","IDNA","LU1069344957.HKD","SG9999001176.SGD","LU1674673428.USD","SGXZ57979304.SGD","IE00B19Z3581.USD","LU1035775433.USD","LU0432979614.USD","BK4121","BK4588","IE00B19Z9P08.USD","LU1674673691.USD","LU0109394709.USD","LU0256863811.USD","IE0002141913.USD","LU2324357040.USD","IE00BJJMRZ35.SGD","VRTX","IBBQ","IE0002270589.USD","LU0289739699.SGD","IE00B19Z9Z06.USD","IE00B894F039.SGD","LU0320765992.SGD","LU0417517546.SGD","BK4532","LU1093756168.USD","LU0823416689.USD","LU2236285917.USD","LU2237438978.USD","LU2417539215.USD","LU2462157665.USD","BIB","IE00B2B36J28.USD","IE00B19Z3B42.SGD","LU0058720904.USD","IE00B4R5TH58.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655884494","title":"安進(AMGN)股票7月28日盤中上漲4.02%：背後推手曝光","url":"https://stock-news.laohu8.com/highlight/detail?id=2655884494","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655884494?lang=zh_tw&edition=fundamental","pubTime":"2026-07-29 02:16","pubTimestamp":1785262601,"startTime":"0","endTime":"0","summary":"• 安进第二季度业绩超预期，并上调了全年业绩指引。\n• 减肥药 MariTide 的积极临床数据推动了股价上涨。\n• 包括 MACD 和 Williams %R 在内的技术指标提示当前为买入信号。","market":"fut","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262059433-market-movers-amgn-20260728","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIB","LU2112291526.USD","LU1057294990.SGD","PJP","BK4588","SG9999001440.SGD","IBB","BK4533","LU0320765992.SGD","BBH","BK4534","LU1571399168.USD","LU1061106388.HKD","BK4566","LU0868494617.USD","LU1023059063.AUD","IE00BJT1NW94.SGD","BK4581","LU2242652126.USD","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","LU0289739699.SGD","BK4139","LU1983299246.USD","IE0002141913.USD","LU0058720904.USD","LU2468319806.SGD","LU2089984988.USD","TBXU","AMGN","BK4585","LU0889565916.HKD","IE0009355771.USD","LU0109394709.USD","PBE","LU0122379950.USD","IE00BFTCPJ56.SGD","BK4599","IBBQ","LU2242646821.SGD","IE00B4R5TH58.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654007935","title":"解讀世界500強排行榜醫藥板塊：強生繼續「霸榜」，禮來排名上升112位，3家中國企業入選","url":"https://stock-news.laohu8.com/highlight/detail?id=2654007935","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654007935?lang=zh_tw&edition=fundamental","pubTime":"2026-07-28 20:51","pubTimestamp":1785243108,"startTime":"0","endTime":"0","summary":"7月28日，2026年《财富》世界500强榜单正式发布。《每日经济新闻》记者注意到，医疗健康板块作为全球五大支柱行业之一，共有31家企业上榜。其中，礼来公司排名从2025年的336位上升至今年的224位，成为今年上涨最快的10家公司之一。中国公司中，中国医药集团、上海医药、广药集团3家公司再次入围。《每日经济新闻》记者注意到，位居医疗健康相关企业榜首的是联合健康集团。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202607283823749452.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202607283823749452.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0528227936.USD","LU1430594728.SGD","BK4568","LU2756315318.SGD","IE00BJLML261.HKD","LU1804176565.USD","THNR","AMGN","IE00B1XK9C88.USD","IE00BJJMRZ35.SGD","LU2361044865.SGD","LU0158827781.USD","LU0170899867.USD","LU0225771236.USD","LU0661504455.SGD","SG9999014914.USD","LU0882574139.USD","LU0342679015.USD","LU0124676726.USD","SG9999017495.SGD","IHE","LU2552382058.USD","LU2265009873.SGD","SG9999015945.SGD","LU2362541513.USD","LU0648001328.SGD","LU0289739343.SGD","PFE","IE000SO60NU8.SGD","LU0466842654.USD","LU0079474960.USD","IE00BVYPNW00.USD","LU2125154935.USD","IE0034235303.USD","LU1261432733.SGD","IE00BKPKM429.USD","LU1119994496.HKD","LU2756315664.SGD","SG9999018865.SGD","ILDR","LU1244550494.USD","LU0820561909.HKD","LU0889566641.SGD","IE0009355771.USD","LU0792757196.USD","LU2264538146.SGD","IE0005OL40V9.USD","IE00BKVL7J92.USD","LU0316494557.USD","IE00BVYPNV92.GBP","IE00B19Z8W00.USD","LU0256863811.USD","LU0211328371.USD","LU0070302665.USD","LU1718418525.SGD","BK4578","LU2347655073.USD","LU0234572021.USD","LU0868494617.USD","LU0238689110.USD","LU0882574055.USD","LU1267930730.SGD","LU0320765992.SGD","LU2242652126.USD","PJP","LU2125909247.SGD","LU1989772840.SGD","LU0345769631.USD","LU1084165304.USD","LU2168564222.USD","IE00BGHQF631.EUR","LU1571399168.USD","LU2129689605.HKD","IE00B19Z9P08.USD","LU0187121727.USD","IE0004445239.USD","IE00BJJMRX11.SGD","CANC","LU0310799852.SGD","BIB","LU1228905037.USD","SG9999014567.USD","LU1506573853.SGD","IE00BKDWB100.SGD","LU0964807845.USD","LU0786609619.USD","BK4559","LU1221951129.SGD","IE00BFTCPJ56.SGD","IE00B7SZLL34.SGD","LU1267930573.SGD","LU0114720955.EUR","GB00BDT5M118.USD","LU1093756168.USD","LU0256863902.USD","LU1854104046.USD","LU1066051811.HKD","LU1712237335.SGD","LU2213496289.HKD","LU0057025933.USD","LU0210536198.USD","LU1037948541.HKD","SG9999015986.USD","SG9999014575.USD","LU0094547139.USD","LU2028103732.USD","LU0011850046.USD","IE00B4R5TH58.HKD","IE00BK4W5L77.USD","LU2237443978.SGD","LU1699723380.USD","LU1923622614.USD","LU0321505868.SGD","RHHBY","LU0417517546.SGD","LU0210528500.USD","LU0942090050.USD","LU1839511570.USD","LU2462591277.SGD","SG9999014880.SGD","SGXZ31699556.SGD","LU1988902786.USD","LU2491050154.USD","LU2063271972.USD","IE000WAW04H5.SGD","LU0174119429.USD","IE00BLSP4239.USD","LU0203347892.USD","LU1732799900.SGD","BK4533","LU1035775433.USD","LU2471134796.USD","LU0738911758.USD","LU0868494708.USD","LU2596442595.SGD","LU1323610961.USD","LU2129689431.USD","LU2087621335.USD","LU1121112475.USD","LU2089283258.USD","LU2403377893.USD","LU1929549753.HKD","LU0266013472.USD","LU0143551892.USD","LU0965509010.AUD","LU1496350502.SGD","LU0225283273.USD","LU2361044949.HKD","LU0310800379.SGD","BK4550","LU2433249047.HKD","BMED","IHF","NVS","TRUH","IE00BFXG1179.USD","LU2954938101.SGD","LU0098860793.USD","LU2089284900.SGD","LU2089984988.USD","IE0004445015.USD","LU2357305700.SGD","LU1883839398.USD","LU2430703178.SGD","UNHW","LU1941712348.USD","LU1791710582.SGD","LU2360032135.SGD","LU0496365809.HKD","BK4588","LU2347655156.SGD","LU0823416689.USD","GDOC","BK4534","LU1069344957.HKD","LU0289961442.SGD","LU0029864427.USD","SG9999014898.SGD","LU0203202063.USD","BK4581","LU0149725797.USD","LU0354030511.USD","LU0640476718.USD","LU0965508806.USD","LU2133065610.SGD","LU1551013425.SGD","IE0001KFT4U8.USD","LU0471298777.SGD","LU2168563687.JPY","LU2430703095.HKD","BK4532","LU2602419157.SGD","LU2552382132.HKD","LU0077335932.USD","LU0225284248.USD","LU1894683348.USD","LU2129689514.USD","LU0980610538.SGD","IE00B4JS1V06.HKD","MRK","LU2362541273.HKD","IE000MB6IJN5.SGD","LU0061475181.USD","LU1791710400.SGD","LU0949170772.SGD","IE0002270589.USD","IE00BN29S564.USD","IE00B775H168.HKD","LU1732800096.USD","LU2023250330.USD","LU1291159041.SGD","LU1941712264.USD","LU2237438978.USD","SG9999015952.SGD","LU0130517989.USD","LU2750360997.AUD","UNHG","LU1228905540.USD","SG9999003800.SGD","JNJ","LU1232071149.USD","ABBV","LU2237443549.SGD","IE00BN8TJ469.HKD","LU1064131342.USD","LU2125909593.SGD","LU1032466523.USD","LU0234570918.USD","LU1496350171.SGD","LU2462157665.USD","IE00BDGV0183.EUR","TMED","LU0823434740.USD","LU1720051017.SGD","LU2456880835.USD","LLY","LU2592432038.USD","LU1629891620.HKD","LU0557290698.USD","JDOC","LU0128525929.USD","UNH","XLV","LU0251132253.USD","LU2236285917.USD","LU0708995401.HKD","LU2023250504.SGD","LU2106854487.HKD","LU2111349929.HKD","LU0323591593.USD","LU0320765059.SGD","LU0861579265.USD","LU2168564149.EUR","LU0133085943.USD","LU1066051225.USD","LU0109394709.USD","CURE","BBH","LU2357627491.SGD","LU1244550221.USD","SG9999001176.USD","LLYX","LU1868836914.USD","IE00B19Z3581.USD","LU2471134523.USD","LU0545039389.USD","LU2279689827.SGD","BK4007","LU0208291251.USD","IE00BWXC8680.SGD","LU0683600562.USD","LU1366192091.USD","LU2023250843.SGD","LU0353189680.USD","LU0070217475.USD","LU0265550946.USD","IE0000B7K699.USD","LU0211331839.USD","LU0385154629.USD","LU0689472784.USD","LU0107464264.USD","LU1974910355.USD","SG9999002224.SGD","PAWZ","LU1548497426.USD","LU0426417589.USD","LU0912757837.SGD","SG9999015341.SGD","IE000M9KFDE8.USD","IE00BLSP4452.SGD","LU2271345857.HKD","LU2471134879.HKD","LU0823434583.USD","LU0203345920.USD","WDNA","LU2023251221.USD","LU2087625088.SGD","LU2237443895.HKD","SGXZ99366536.SGD","LU0726765562.USD","LU1061106388.HKD","LU0289739699.SGD","LU1043141396.HKD","LU1244550577.SGD","FHLC","LU0545562505.USD","LU1221951046.USD","LU1935042991.SGD","LU1989771016.USD","SG9999015978.USD","LU2746668974.SGD","LU1127390331.HKD","IE00B19Z3B42.SGD","LU0052756011.USD","LU0211327993.USD","LU1894683264.USD","LU1623119135.USD","LU2750360641.GBP","LU2505996509.AUD","LU1057294990.SGD","LU2211815571.USD","LU2491050071.SGD","BK4566","BK4585","LU1043141123.HKD","IBBQ","IXJ","IE00B19Z8X17.USD","IE00B894F039.SGD","LU0345770308.USD","LU1551013342.USD","LU0471298694.HKD","LU1983299246.USD","LU1201861249.SGD","LU0965509101.SGD","LU0122379950.USD","LU0672654240.SGD","NVOX","LU0130102774.USD","LU1116320901.HKD","LU0787776722.HKD","BK4592","VHT","LU1069347547.HKD","LU0198837287.USD","ELIS","SGXZ81514606.USD","PBE","IBB","LU2237443382.USD","LU0345770993.USD","LU2112291526.USD","SG9999013999.USD","LU1074936037.SGD","LU1032955483.USD","HRTS","LU0211326839.USD","LU2237443622.USD","LU0943347566.SGD","LU2487616109.SGD","UNHU","IE00B3PB1722.GBP","BK4139","LU0708994859.HKD","LU2746668461.USD","SGXZ51526630.SGD","LU0965509283.SGD","LU1914381329.SGD","LU2552382215.SGD","IE00B3T34201.USD","LU0058720904.USD","IE000F7OJYX1.SGD","LU0477156953.USD","LU1868836757.USD","LLII","OZEM","LU0211326755.USD","LU1670627923.USD","LU0128525689.USD","LU0553294199.USD","LU2242649171.HKD","LU2417539215.USD","LU1093756325.SGD","LU0109391861.USD","LU1814569148.SGD","SG9999018857.SGD","RXL","LU2999663052.SGD","LU0472753341.HKD","LU0320765646.SGD","LU0395794307.EUR","SGXZ57979304.SGD","LU2242646821.SGD","LU1023059063.AUD","IE00B1BXHZ80.USD","LU1868837300.USD","LU0158827948.USD","LU0432979614.USD","LU0069063385.USD","IYH","LU0354030438.USD","LU1162221912.USD","IE00BZ9MQY76.HKD","IE00BJJMRY28.SGD","MEDX","IE00B2B36J28.USD","IE00BFSS8Q28.SGD","LU0689626769.HKD","LU0795875086.SGD","LU0265550359.USD","LU1670628061.USD","BK4599","IE00B19Z9505.USD","LU0106261372.USD","LU0006306889.USD","SG9999002232.USD","LU2505996681.GBP","LU1854103824.USD","LU0456855351.SGD","LU1267930813.SGD","LU1066051498.USD","LU1196500208.SGD","NVOH","LU2461242641.AUD","LU2362540622.SGD","LU0994945656.USD","LU1145028129.USD","PPH","LU0096364046.USD","LU1059921491.USD","SG9999014559.SGD","LU2168564065.EUR","SG9999001176.SGD","LU0310800965.SGD","IE00BBT3K403.USD","LU0321505439.SGD","LU1035773651.USD","NVO","LU1868837136.USD","LU1674673691.USD","LU0306807586.USD","IE00BJT1NW94.SGD","LU1003077747.HKD","LU2360106947.USD","LU1934455863.HKD","04332","IE0002141913.USD","MEDI","IE00BZ1G4Q59.USD","LU2361045086.USD","LU1989772923.USD","SG9999015358.SGD","IE00BFSS7M15.SGD","LU0820561818.USD","LU0795875169.SGD","LU0985481810.HKD","LU2244417387.USD","LU0345769128.USD","LU0820562030.AUD","LU2237443465.HKD","LU1153585028.USD","LU0072461881.USD","LU0203201768.USD","LU1934455277.USD","GLAM","BK4516","LU1934455194.USD","LU0162691827.USD","LU0889565916.HKD","LU1868836591.USD","LU1674673428.USD","LU2462591350.SGD","LU2471134952.CNY","LU2430703251.USD","LU0511384066.AUD","LLYZ","LU1116320737.USD","LU0353189763.USD","LU2125154778.USD","SG9999001440.SGD","LU0154236417.USD","LU1267930490.SGD","LU0306806265.USD","LU1066053197.SGD","LU2491049909.HKD","LU1720051108.HKD","LU1585245621.USD","LU1778281490.HKD","LU1917777945.USD","TBXU","LU0320765489.SGD","LU0859254822.USD","LU0097036916.USD","IE00B19Z9Z06.USD","LU2324357040.USD","ELIL","LU0053666078.USD","AGNG","IE00BK4W5M84.HKD","SG9999011175.SGD","SG9999014906.USD","IE00BSNM7G36.USD","IE000BZT7R73.USD","MHIP","LU0048584097.USD","LU2168564495.EUR","LU1280957306.USD","SG9999014542.SGD","LU0426412945.USD","BK4154","LU0985320562.USD","FTXH","BK4504","IE00B7KXQ091.USD","IE00B42XCP33.USD","LU1267930227.SGD","LU2896262040.SGD","LU2468319806.SGD","LU0976567544.SGD","LU2108987350.USD","03165","LU1037948897.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654027040","title":"Bitget 已上線 SKDD、GILD、TMF 等 9 只股票永續合約","url":"https://stock-news.laohu8.com/highlight/detail?id=2654027040","media":"链捕手","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654027040?lang=zh_tw&edition=fundamental","pubTime":"2026-07-28 11:11","pubTimestamp":1785208272,"startTime":"0","endTime":"0","summary":" ChainCatcher 消息，据官方公告，为满足用户多元化投资需求，Bitget 已上线 SKDD（2 倍做空 SK 海力士 ETF）、SKUU（2 倍做多 SK 海力士 ETF）、GILD（Gilead Sciences）、TMF（3 倍做多美国长期国债 ETF）等 9 只股票及 ETF 永续合约。\n\n上述合约均以 USDT 结算，支持最高 20 倍杠杆和 7×24 小时交易。更多详情可参阅 Bitget 官方平台。\n\n\n ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.chaincatcher.com/article/2278557","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999015978.USD","GILD","LU0965508806.USD","IE00B7SZLL34.SGD","LU1674673428.USD","BK4550","LU0965509283.SGD","SG9999015952.SGD","LU1430594728.SGD","LU1066053197.SGD","LU1839511570.USD","LU1674673691.USD","LU0122379950.USD","LU1061106388.HKD","IE00B19Z3581.USD","IBBQ","IE00BKVL7J92.USD","LU0289739699.SGD","LU1037948541.HKD","TBXU","LU1934455863.HKD","MEDI","LU0882574055.USD","LU0861579265.USD","IE00B19Z3B42.SGD","SG9999015986.USD","TMED","BMED","BK4578","IBB","BBH","SG9999015945.SGD","LU2112291526.USD","BK4583","BK4588","LU0058720904.USD","BK4532","BIB","LU0109394709.USD","LU1934455194.USD","LU0114720955.EUR","LU0965509101.SGD","LU0823416689.USD","LU0965509010.AUD","LU2324357040.USD","LU0320765992.SGD","LU1934455277.USD","BK4139","BK4566","IE0002270589.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653080634","title":"安進提交新數據，對美國食品藥品監督管理局（FDA）關於撤回Tavneos的提議提出異議","url":"https://stock-news.laohu8.com/highlight/detail?id=2653080634","media":"路透中文","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653080634?lang=zh_tw&edition=fundamental","pubTime":"2026-07-24 21:44","pubTimestamp":1784900670,"startTime":"0","endTime":"0","summary":"安进提交新数据，对美国食品药品监督管理局关于撤回Tavneos的提议提出异议路透7月24日-安进公司周五表示，该公司已于7月23日向美国食品药品监督管理局提交了新证据，以寻求举行听证会，对该公司的罕见病药物Tavneos拟从美国市场撤回的决定提出异议。美国食品药品监督管理局未立即回应路透的置评请求。美国食品药品监督管理局今年4月表示，除非安进公司主动撤回该药，或FDA局长下令撤回，否则Tavneos将继续在美国市场销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260724:nL4T43Q16X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIB","LU2112291526.USD","LU1057294990.SGD","PJP","BK4588","SG9999001440.SGD","IBB","BK4533","LU0320765992.SGD","BBH","BK4534","LU1571399168.USD","LU1061106388.HKD","BK4566","LU0868494617.USD","LU1023059063.AUD","IE00BJT1NW94.SGD","BK4581","LU2242652126.USD","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","LU0289739699.SGD","BK4139","LU1983299246.USD","IE0002141913.USD","LU0058720904.USD","LU2468319806.SGD","LU2089984988.USD","TBXU","AMGN","BK4585","LU0889565916.HKD","IE0009355771.USD","LU0109394709.USD","PBE","LU0122379950.USD","IE00BFTCPJ56.SGD","BK4599","IBBQ","LU2242646821.SGD","IE00B4R5TH58.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653895100","title":"吉利德科學(GILD)腫瘤組合療法獲歐洲藥品管理局旗下CHMP推薦","url":"https://stock-news.laohu8.com/highlight/detail?id=2653895100","media":"金吾财讯","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653895100?lang=zh_tw&edition=fundamental","pubTime":"2026-07-24 18:45","pubTimestamp":1784889935,"startTime":"0","endTime":"0","summary":"金吾财讯 | 吉利德科学 宣布，欧洲药品管理局旗下人用药品委员会已发布积极意见，建议批准其Trop-2靶向ADC药物Trodelvy联合帕博利珠单抗，用于既往未接受过全身治疗、且肿瘤PD-L1表达阳性的不可切除局部晚期或转移性三阴性乳腺癌成人患者。若欧盟委员会于2026年晚些时候正式批准该联合疗法，Trodelvy将实现从单药到联合疗法、全面覆盖不同PD-L1表达状态的mTNBC一线治疗布局。","market":"sh","thumbnail":"https://static.szfiu.com/news/20210810/NmQ4YmNlMWEyMTYyODU5MDQwMjQzMA==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/NmQ4YmNlMWEyMTYyODU5MDQwMjQzMA==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"302998","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4578","IBB","BK4139","LU2468319806.SGD","TBXU","LU0320765992.SGD","MEDI","IE0002270589.USD","LU2089984988.USD","IE00BSNM7G36.USD","LU0823416689.USD","LU1934455194.USD","IE00BZ1G4Q59.USD","LU0965509010.AUD","LU1037948541.HKD","LU1585245621.USD","SG9999015945.SGD","LU0122379950.USD","GILD","BIB","SG9999015978.USD","LU0965509101.SGD","LU0965508806.USD","LU2324357040.USD","CHMP","LU1571399168.USD","BK4588","SG9999015952.SGD","LU1061106388.HKD","LU1934455863.HKD","BK4583","LU2087621335.USD","BMED","BK4550","IBBQ","LU0058720904.USD","LU0234570918.USD","TMED","BK4585","LU0889565916.HKD","LU1023059063.AUD","IE00B19Z3581.USD","IE00B3T34201.USD","LU1066051498.USD","BK4568","SG9999015986.USD","BBH","LU1057294990.SGD","LU0289739699.SGD","LU1674673428.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185859812","title":"CHMP推薦吉利德Trodelvy®聯合Keytruda®用於PD-(L)1陽性一線轉移性三陰性乳腺癌","url":"https://stock-news.laohu8.com/highlight/detail?id=1185859812","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185859812?lang=zh_tw&edition=fundamental","pubTime":"2026-07-24 18:29","pubTimestamp":1784888958,"startTime":"0","endTime":"0","summary":"欧洲药品管理局人用药品委员会（CHMP）近日给出推荐意见，支持吉利德科学的Trodelvy®与Keytruda®联合使用，用于治疗PD-(L)1阳性的一线转移性三阴性乳腺癌患者。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2087621335.USD","IE00B7SZLL34.SGD","TMED","LU2112291526.USD","LU1430594728.SGD","BK4568","BK4139","LU1571399168.USD","IE0002270589.USD","IE00B19Z3581.USD","IE00BKVL7J92.USD","LU1778281490.HKD","LU1934455863.HKD","LU0234570918.USD","LU0861579265.USD","SG9999015978.USD","LU1037948541.HKD","LU2089984988.USD","LU1934455194.USD","IE00B19Z3B42.SGD","GILD","BMED","IE00BZ1G4Q59.USD","BK4585","LU0289739699.SGD","TBXU","BK4578","LU0122379950.USD","BK4588","IBB","SG9999015945.SGD","LU2468319806.SGD","LU1057294990.SGD","LU1839511570.USD","LU1061106388.HKD","LU1023059063.AUD","IE00BSNM7G36.USD","LU1585245621.USD","LU0058720904.USD","IE00B3T34201.USD","IBBQ","LU0965509101.SGD","BIB","LU1674673691.USD","BK4532","SG9999015986.USD","LU0320765992.SGD","BBH","LU0965509283.SGD","LU0109394709.USD","LU0965509010.AUD","LU1066051498.USD","MEDI","LU2324357040.USD","BK4583","LU1066053197.SGD","LU1674673428.USD","LU0889565916.HKD","SG9999015952.SGD","LU0965508806.USD","BK4550","LU0114720955.EUR","LU0882574055.USD","LU1934455277.USD","LU1037948897.HKD","LU0823416689.USD","BK4566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653074709","title":"百濟神州/安進 FIC 雙抗，皮下製劑進入 III 期","url":"https://stock-news.laohu8.com/highlight/detail?id=2653074709","media":"新浪医药","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653074709?lang=zh_tw&edition=fundamental","pubTime":"2026-07-23 19:30","pubTimestamp":1784806200,"startTime":"0","endTime":"0","summary":"7 月 22 日，药物临床试验登记与信息公示平台显示，安进和百济神州共同登记了一项在接受含铂一线化疗后的复发性广泛期小细胞肺癌试验参与者中比较 Tarlatamab皮下给药与静脉给药的 III 期研究DeLLphi-315。在皮下剂型的开发方面，安进和百济神州于 2024 年 9 月启动了一项在广泛期小细胞肺癌受试者中评价 Tarlatamab 皮下给药的安全性、耐受性、药代动力学和初步抗肿瘤活性的 Ib 期研究 DeLLphi-308。而本次启动的DeLLphi-315 研究是塔拉妥单抗皮下给药方案启动的首个 III 期临床试验。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/hk/2026-07-23/doc-iniivazc5268721.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["06160","LU0058720904.USD","LU2242646821.SGD","LU1251922891.USD","BK4588","LU0868494617.USD","IE00B4R5TH58.HKD","TBXU","BK4581","LU0122379950.USD","BK1588","IBB","IE0002141913.USD","IE0009355771.USD","PBE","BK1500","LU2242652126.USD","IE00BJT1NW94.SGD","LU2328871848.SGD","688235","III","LU0320765992.SGD","BK4599","LU1969619763.USD","LU0289739699.SGD","SG9999001440.SGD","LU2468319806.SGD","ONC","IE00BFTCPJ56.SGD","AMGN","LU0889565916.HKD","LU2112291526.USD","LU0588546209.SGD","BBH","BK4134","LU1983299246.USD","PJP","BK4534","IBBQ","BK4139","BIB","LU0307460666.USD","LU1061106388.HKD","KURE","LU1303224171.USD","LU1770034418.SGD","LU1719994722.HKD","BK4585","LU1571399168.USD","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653749341","title":"argenx(ARGX)二季度產品淨銷售額達15.16億美元 按年增長60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2653749341","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653749341?lang=zh_tw&edition=fundamental","pubTime":"2026-07-23 18:18","pubTimestamp":1784801894,"startTime":"0","endTime":"0","summary":"金吾财讯 | 全球自身免疫疾病龙头生物科技公司 argenx 发布了2026年第二季度及上半年财报。其中，2026年第二季度，公司实现产品净销售额 15.16亿美元，同比大幅增长 60%，环比增长 17%。资金储备方面，截至2026年6月30日，argenx 拥有的现金、现金等价物及流动金融资产达 52亿美元，显著高于2025年底的44亿美元，为后续临床研发及商业化扩张提供了雄厚的资金屏障。截至2026年底，argenx 预计将有10款药物分子处于临床研发阶段。","market":"sg","thumbnail":"https://static.szfiu.com/news/20210810/ODM0ODU4NWZiOGY2NDQ4NTA4OTM0NDg5MTI=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/ODM0ODU4NWZiOGY2NDQ4NTA4OTM0NDg5MTI=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"302939","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0009355771.USD","ARGX","LU0320765992.SGD","IE00BFTCPJ56.SGD","FMED","TBXU","BK4139","IBB","IE0034235188.USD","LU0109394709.USD","IE00B4R5TH58.HKD","IE00BJT1NW94.SGD","LU1983260115.SGD","BK4505","BK4585","BK4588","LU0889565916.HKD","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","IE0002141913.USD","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653712957","title":"美國研究綜述-Alphabet、IBM、特斯拉","url":"https://stock-news.laohu8.com/highlight/detail?id=2653712957","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653712957?lang=zh_tw&edition=fundamental","pubTime":"2026-07-23 15:30","pubTimestamp":1784791811,"startTime":"0","endTime":"0","summary":"美国研究综述-Alphabet、IBM、特斯拉路透7月23日-周四，华尔街证券分析师调整了包括Alphabet、IBM和特斯拉在内的多家美国上市公司评级及目标股价。股票按字母顺序排列。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260723:nL4T43P0KW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SKYY","DIG","GILD","MCB","GSHD","MPC","ROL","MNPR","GOOW","SF","T","RJF","BMI","IPAR","PEGA","ARWR","CME","NOC","CVX","PSX","CCI","EOG","EFX","KDP","KNX","CELH","SEIC","AMDS","WUGI","IBM","ARTY","BP","AMD","EWBC","NTRS","FTNT","XOM","BAI","SNDK","CASH","GOOX","CVNA","EFIV","GEV","GOOGL","BLFS","FTAI","IBB","CLIX","CDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653618768","title":"數據簡報-邦迪布吉奧埃博拉病毒：正在研發哪些疫苗和治療方法","url":"https://stock-news.laohu8.com/highlight/detail?id=2653618768","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653618768?lang=zh_tw&edition=fundamental","pubTime":"2026-07-22 20:52","pubTimestamp":1784724736,"startTime":"0","endTime":"0","summary":"数据简报-邦迪布吉奥埃博拉病毒：正在研发哪些疫苗和治疗方法更新疫情数据，补充临床试验进展及诊断检测详情Mariam Sunny/Jennifer Rigby路透7月22日-全球卫生部门正争分夺秒地寻找医疗方案，以遏制刚果民主共和国东部由邦迪布吉奥  埃博拉病毒株引发的疫情。与更常见的扎伊尔毒株不同，目前尚无针对邦迪布吉奥毒株的获批疫苗或治疗方法。据该公司称，实验室研究表明该药物对邦迪布吉奥埃博拉病毒具有活性。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260722:nL4T43O1A0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1015430645.USD","LU1430594728.SGD","BK4568","REGN","LU3187612489.SGD","IE00BJJMRZ35.SGD","LU2361044865.SGD","LU0920840948.USD","LU0661504455.SGD","LU1355424745.HKD","LU0124676726.USD","LU0047473722.EUR","LU1196032939.SGD","IHE","SG9999015945.SGD","LU2362541513.USD","LU1019632923.USD","LU0648001328.SGD","BK0239","LU0969580561.USD","LU0972486137.USD","LU2125154935.USD","BK4583","LU1261432733.SGD","LU1119994496.HKD","LU0171293334.USD","LU0784384876.USD","IE0009355771.USD","LU0889566641.SGD","LU0792757196.USD","IE00BKVL7J92.USD","LU1003076772.USD","LU0211328371.USD","LU0070302665.USD","LU0857590862.USD","BK4578","LU0234572021.USD","LU0868494617.USD","LU0238689110.USD","LU0882574055.USD","LU0320765992.SGD","LU1481599808.USD","LU1153584641.USD","LU0640478417.SGD","LU0784385840.USD","LU2125909247.SGD","LU2114397693.USD","LU1989772840.SGD","LU1084165304.USD","LGHT","LU1571399168.USD","LU0310799852.SGD","BIB","SG9999014567.USD","BK4559","IE00BFTCPJ56.SGD","IE00B7SZLL34.SGD","LU1267930573.SGD","LU0114720955.EUR","LU1093756168.USD","LU1066051811.HKD","SG9999015986.USD","LU1037948541.HKD","GILD","SG9999014575.USD","LU0011850046.USD","IE00B4R5TH58.HKD","LU2237443978.SGD","LU1051770623.HKD","LU1699723380.USD","LU1923622614.USD","LU0942090050.USD","LU1839511570.USD","LU0889565080.SGD","LU2491050154.USD","LU0499090636.EUR","IE00BLSP4239.USD","LU0203347892.USD","BK4533","LU0738911758.USD","LU0868494708.USD","LU0997586515.USD","LU1323610961.USD","AZN.UK","LU2087621335.USD","LU2089283258.USD","LU1929549753.HKD","LU0266013472.USD","LU0965509010.AUD","LU1496350502.SGD","LU2361044949.HKD","LU0310800379.SGD","BK4550","LU2433249047.HKD","BMED","LU0784383803.USD","TRUH","LU0098860793.USD","LU2089284900.SGD","LU1863844665.USD","LU2089984988.USD","LU0997586432.USD","LU1941712348.USD","LU0047473722.SGD","LU2360032135.SGD","LU0496365809.HKD","BK4588","LU0823416689.USD","GDOC","BK4534","LU0029864427.USD","LU2133065610.SGD","LU0965508806.USD","LU0823399737.USD","BK4532","LU0077335932.USD","LU0960981461.USD","LU0980610538.SGD","MRK","LU2362541273.HKD","LU0887340254.USD","IE0002270589.USD","LU0949170772.SGD","IE00BKPKM643.USD","LU1291159041.SGD","LU1941712264.USD","LU2237438978.USD","SG9999015952.SGD","LU0130517989.USD","LU0963555726.SGD","LU1487256676.USD","LU2237443549.SGD","IE00BN8TJ469.HKD","LU2125909593.SGD","LU1019634622.SGD","LU0234570918.USD","LU1496350171.SGD","TMED","LU0823434740.USD","LU0557290698.USD","JDOC","LU0128525929.USD","XLV","LU2023250504.SGD","LU2106854487.HKD","LU0861579265.USD","LU0964806797.USD","LU1066051225.USD","LU0109394709.USD","LU2357627491.SGD","BBH","SG9999001176.USD","IE00B19Z3581.USD","LU0545039389.USD","LU2279689827.SGD","BK4007","LU0208291251.USD","LU2023250843.SGD","LU0265550946.USD","LU0211331839.USD","MRNY","LU1974910355.USD","SG9999002224.SGD","OSUR","PAWZ","LU1046234339.USD","LU1170363599.USD","SG9999015341.SGD","IE000M9KFDE8.USD","IE00BLSP4452.SGD","LU0823434583.USD","LU0203345920.USD","WDNA","LU0920783379.SGD","LU2023251221.USD","IE0034235188.USD","LU2237443895.HKD","LU1061106388.HKD","LU0289739699.SGD","FHLC","LU1989771016.USD","SG9999015978.USD","LU0345777147.USD","LU1301847155.USD","IE00B19Z3B42.SGD","LU0052756011.USD","LU0211327993.USD","LU0827474353.SGD","LU0171276677.USD","LU0957799991.USD","LU1057294990.SGD","LU2491050071.SGD","BK4566","BK4585","LU0757432116.USD","IBBQ","IXJ","LU1983299246.USD","LU1201861249.SGD","LU0965509101.SGD","LU0949170426.SGD","LU0122379950.USD","LU0130102774.USD","LU1116320901.HKD","VHT","LU1069347547.HKD","IBB","LU2237443382.USD","SG9999013999.USD","LU2112291526.USD","LU0784385170.HKD","LU1273509221.SGD","HRTS","LU0211326839.USD","MRNX","LU2237443622.USD","LU1104425308.USD","MRNA","BK4139","LU0708994859.HKD","LU2293690249.USD","LU0965509283.SGD","IE00B3T34201.USD","LU0058720904.USD","LU0477156953.USD","BK5011","LU0211326755.USD","LU0526926950.USD","LU0128525689.USD","LU0553294199.USD","LU1481600234.SGD","LU1093756325.SGD","LU1814569148.SGD","BK4551","RXL","LU1863844749.USD","LU0320765646.SGD","SGXZ57979304.SGD","LU1023059063.AUD","GNOM","IE00B1BXHZ80.USD","LU0158827948.USD","LU0432979614.USD","IYH","LU1880407215.USD","LU1162221912.USD","IE00B2B36J28.USD","LU0689626769.HKD","LU0265550359.USD","LU0106261372.USD","SG9999002232.USD","LU0006306889.USD","LU1267930813.SGD","LU1066051498.USD","LU2461242641.AUD","LU2362540622.SGD","BK4501","LU1829250122.USD","PPH","SG9999014559.SGD","688317","IDNA","LU2539964713.USD","SG9999001176.SGD","LU0310800965.SGD","IE00BBT3K403.USD","LU1035773651.USD","LU2293690082.USD","LU1674673691.USD","LU1003077747.HKD","IE00BJT1NW94.SGD","LU0345777659.USD","LU1934455863.HKD","IE0002141913.USD","MEDI","IE00BZ1G4Q59.USD","LU2361045086.USD","LU1989772923.USD","SG9999015358.SGD","LU2237443465.HKD","LU1064927863.SGD","LU1153585028.USD","LU1934455277.USD","BK4516","BK4548","LU1934455194.USD","LU0889565916.HKD","LU1674673428.USD","LU1078025761.USD","LU1880407132.USD","LU0390134368.USD","LU1116320737.USD","LU2355687059.USD","LU2125154778.USD","SG9999001440.SGD","LU1267930490.SGD","LU1066053197.SGD","LU2491049909.HKD","LU1585245621.USD","LU1778281490.HKD","LU1917777945.USD","TBXU","LU0320765489.SGD","LU0859254822.USD","LU2324357040.USD","LU0053666078.USD","LU2091194634.USD","IE00BSNM7G36.USD","SG9999014542.SGD","BK4198","LU0985320562.USD","FTXH","LU1267930227.SGD","LU2468319806.SGD","LU0976567544.SGD","LU2108987350.USD","LU0575583348.USD","03165","LU1037948897.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653584157","title":"創新藥研發加速遇「猴荒」","url":"https://stock-news.laohu8.com/highlight/detail?id=2653584157","media":"三里河","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653584157?lang=zh_tw&edition=fundamental","pubTime":"2026-07-22 16:21","pubTimestamp":1784708497,"startTime":"0","endTime":"0","summary":"“要站在‘猴’里，不要像猴子一样站在那里。”资本市场从来不缺故事。近期，昭衍新药业绩暴增，原因是实验猴市场价格上涨，带动公司手里的“猴子资产”大幅增值，多家相关概念公司股价也跟风大涨。甚至有人顺藤摸瓜，挖出了“香蕉概念”。网友戏称：这是产业链挖掘最深的一次。一只猴子，为什么能扰动资本市场？答案藏在药物的研发链条里。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202607223817277458.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202607223817277458.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["PBE","SBIO","GSKH","BBP","XLVI","BIOY","APXH","LFSC","BK4585","WRND","IBB","GDOC","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653204798","title":"吉利德與默克聯合研發的每周服用一次的艾滋病口服藥在晚期臨床試驗中成功抑制了病毒","url":"https://stock-news.laohu8.com/highlight/detail?id=2653204798","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653204798?lang=zh_tw&edition=fundamental","pubTime":"2026-07-22 01:23","pubTimestamp":1784654592,"startTime":"0","endTime":"0","summary":"吉利德与默克联合研发的每周服用一次的艾滋病口服药在晚期临床试验中成功抑制了病毒路透7月21日-吉利德科学公司和默克公司周二表示，其正在试验中的每周服用一次的艾滋病毒口服药在两项晚期临床试验中成功抑制了病毒，这为该药的监管申报提供了支持，该疗法有望成为此类疾病治疗中首个此类方案。默克公司的每日一次艾滋病口服复方制剂Idvynso已于4月获得美国食品药品监督管理局批准 ，为艾滋病患者提供了另一种治疗选择。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260721:nL4T43N1N1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014542.SGD","VHT","LU0266013472.USD","RXL","LU2023250843.SGD","LU0432979614.USD","TBXU","IE00B2B36J28.USD","LU1291159041.SGD","PPH","MRK","TMED","LU1778281490.HKD","LU1941712348.USD","LU2089984988.USD","LU0889565916.HKD","BMED","BIB","IE00BJJMRZ35.SGD","GILD","LU1066053197.SGD","LU1923622614.USD","LU1983299246.USD","BBH","HRTS","MEDI","JDOC","TRUH","GDOC","LU1699723380.USD","LU0861579265.USD","LU1929549753.HKD","SG9999001176.USD","LU1023059063.AUD","LU2087621335.USD","LU0058720904.USD","FHLC","LU1989771016.USD","IBBQ","LU2324357040.USD","XLV","IBB","LU0868494708.USD","IXJ","IYH","LU1093756168.USD","IHE","SG9999015952.SGD","FTXH","PAWZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653206285","title":"安進就股東提起的指控其隱瞞107億美元税單的訴訟達成和解","url":"https://stock-news.laohu8.com/highlight/detail?id=2653206285","media":"路透中文","labels":["policyRegulatory","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653206285?lang=zh_tw&edition=fundamental","pubTime":"2026-07-21 23:07","pubTimestamp":1784646437,"startTime":"0","endTime":"0","summary":"安进就股东提起的指控其隐瞒107亿美元税单的诉讼达成和解Jonathan Stempel路透纽约7月21日-安进公司就一起指控其延迟披露可能因六年税款申报不足而需向美国国税局补缴107亿美元的诉讼，达成了一项7400万美元的和解协议。安进否认有任何不当行为，并于周二表示仍认为这些指控毫无依据。美国国税局就安进公司所谓的“转让定价”做法，要求其补缴87亿美元税款及利息，并处以20亿美元罚款。安进公司表示，美国税务法院的裁决可能于今年作出。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260721:nL4T43N1GC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TBXU","BBH","BK4588","LU2112291526.USD","BK4533","BK4566","AMGN","BK4585","IBBQ","BIB","PBE","LU1571399168.USD","LU1983299246.USD","LU0289739699.SGD","BK4534","BK4139","IE00BJT1NW94.SGD","LU1061106388.HKD","LU2242646821.SGD","SG9999001440.SGD","LU0058720904.USD","LU1057294990.SGD","LU0320765992.SGD","PJP","IE00BJJMRZ35.SGD","LU0122379950.USD","LU0868494617.USD","LU1023059063.AUD","LU0889565916.HKD","IE0009355771.USD","BK4581","IE0002141913.USD","LU0109394709.USD","IE00B4R5TH58.HKD","LU2089984988.USD","IE00B2B36J28.USD","LU2242652126.USD","IE00BFTCPJ56.SGD","BK4599","LU2468319806.SGD","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169878111","title":"Leerink Partners下調吉利德科學評級至「與大盤持平」，目標價大幅調降至127美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1169878111","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169878111?lang=zh_tw&edition=fundamental","pubTime":"2026-07-21 12:03","pubTimestamp":1784606620,"startTime":"0","endTime":"0","summary":"投资银行Leerink Partners调整了对生物技术公司吉利德科学的股票评级。该机构将其评级从原先的“跑赢大盘”下调至“与大盘持平”，反映出其对该公司近期前景更为审慎的看法。\n与此同时，Leerink Partners也显著下调了吉利德科学的目标股价，从每股146美元大幅削减至127美元。这一调整意味着该机构对该公司未来股价的预期有所降低。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3T34201.USD","BMED","LU0320765992.SGD","LU0889565916.HKD","LU1066051498.USD","LU1674673691.USD","MEDI","GILD","LU1057294990.SGD","LU1934455194.USD","LU1674673428.USD","LU1037948541.HKD","LU1839511570.USD","LU1037948897.HKD","SG9999015952.SGD","LU1778281490.HKD","IBBQ","LU1430594728.SGD","BK4578","LU2112291526.USD","TBXU","LU0965509101.SGD","BK4139","IBB","IE0002270589.USD","LU1934455863.HKD","LU2089984988.USD","LU0965508806.USD","BK4566","IE00BZ1G4Q59.USD","SG9999015945.SGD","BBH","LU1571399168.USD","IE00BKVL7J92.USD","LU0109394709.USD","LU0114720955.EUR","LU2468319806.SGD","TMED","BK4550","BK4568","BIB","LU0861579265.USD","SG9999015978.USD","LU0882574055.USD","LU0965509010.AUD","IE00BSNM7G36.USD","BK4583","IE00B7SZLL34.SGD","LU0122379950.USD","BK4532","LU0289739699.SGD","LU0058720904.USD","LU0965509283.SGD","LU1585245621.USD","LU1934455277.USD","LU1061106388.HKD","LU2087621335.USD","SG9999015986.USD","IE00B19Z3581.USD","IE00B19Z3B42.SGD","LU0234570918.USD","LU1023059063.AUD","LU1066053197.SGD","BK4588","LU0823416689.USD","BK4585","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653210240","title":"Leerink下調吉利德科學目標價至127美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2653210240","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653210240?lang=zh_tw&edition=fundamental","pubTime":"2026-07-21 10:35","pubTimestamp":1784601350,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4139","LU0114720955.EUR","LU0058720904.USD","LU1778281490.HKD","LU1674673691.USD","LU1037948541.HKD","LU1023059063.AUD","IE00BZ1G4Q59.USD","LU0889565916.HKD","IE00BKVL7J92.USD","LU1585245621.USD","BK4550","LU2468319806.SGD","SG9999015978.USD","BK4585","IE00B19Z3B42.SGD","LU0965509010.AUD","LU1066053197.SGD","BK4583","LU0109394709.USD","LU0965509101.SGD","LU0320765992.SGD","BMED","LU1674673428.USD","IE00BSNM7G36.USD","GILD","UUP","MEDI","BIB","UDN","LU0234570918.USD","IBBQ","LU2087621335.USD","BBH","LU0122379950.USD","LU0861579265.USD","LU1839511570.USD","LU1934455863.HKD","IE00B7SZLL34.SGD","LU0823416689.USD","LU2324357040.USD","BK4578","IBB","SG9999015986.USD","LU0965509283.SGD","LU2112291526.USD","LU0882574055.USD","LU2089984988.USD","SG9999015945.SGD","LU0289739699.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652423028","title":"Kalshi將允許對臨床試驗和FDA決定進行投注","url":"https://stock-news.laohu8.com/highlight/detail?id=2652423028","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652423028?lang=zh_tw&edition=fundamental","pubTime":"2026-07-16 23:59","pubTimestamp":1784217550,"startTime":"0","endTime":"0","summary":"Kalshi将允许对临床试验和FDA决定进行投注路透7月16日-预测市场平台Kalshi周四表示，将开始接受针对临床试验结果和美国食品药品监督管理局监管审查结果的投注，这标志着药物研发的赔率首次向公众公开。Kalshi表示，这些市场允许投资者针对单一药物而非整个公司进行投注。Kalshi和AppliedXL将在试验完成受试者招募后才发布相关合约。Kalshi平台于2021年上线，允许用户对体育赛事、选举结果和天气等事件进行投注。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260716:nL4S43I1IP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1061106388.HKD","IE00B19Z3B42.SGD","LU1037948541.HKD","LU0823416689.USD","SG9999015978.USD","LU0889565916.HKD","BK4578","LU0965509283.SGD","SG9999015945.SGD","LU0122379950.USD","LU1585245621.USD","LU1839511570.USD","LU2112291526.USD","SMMT","LU0058720904.USD","BK4588","LU1066051498.USD","LU2089984988.USD","LU0965508806.USD","LU0109394709.USD","LU1934455277.USD","BIB","BK4585","LU1057294990.SGD","BMED","IE00BSNM7G36.USD","IE0002270589.USD","LU1674673428.USD","LU2324357040.USD","LU1934455863.HKD","IE00B7SZLL34.SGD","IBB","LU1571399168.USD","LU2087621335.USD","BK4532","IE00B19Z3581.USD","LU2468319806.SGD","LU0114720955.EUR","LU1037948897.HKD","LU1674673691.USD","SG9999015952.SGD","IBBQ","BBH","LU0861579265.USD","MEDI","BK4583","BK4566","GILD","LU0234570918.USD","LU0882574055.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651495621","title":"三星生物製劑與歐加農將在澳大利亞推出新型生物類似藥。","url":"https://stock-news.laohu8.com/highlight/detail?id=2651495621","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651495621?lang=zh_tw&edition=fundamental","pubTime":"2026-07-16 04:04","pubTimestamp":1784145897,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4585","LU2272731865.HKD","EMXC","BK4588","LU2272731600.USD","IE00B5TLWC47.USD","LU2322448791.USD","LU2473716301.USD","LU2322448957.HKD","LU1992135472.HKD","XPH","PPH","LU2272731782.SGD","IBB","LU1992135399.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651105068","title":"剛果啓動吉利德實驗性抗病毒藥物邦迪布吉奧埃博拉病毒試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=2651105068","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651105068?lang=zh_tw&edition=fundamental","pubTime":"2026-07-14 20:47","pubTimestamp":1784033246,"startTime":"0","endTime":"0","summary":"刚果启动吉利德实验性抗病毒药物邦迪布吉奥埃博拉病毒试验路透7月14日-刚果民主共和国的研究人员周二表示，他们已开始招募受试者，参与一项临床试验，测试吉利德科学公司GILD.O旗下实验性抗病毒药物奥贝德西韦作为刚果和乌干达当前邦迪布吉奥埃博拉疫情的暴露后治疗药物。在临床前研究中，奥贝德西韦已显示出对丝状病毒的活性。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260714:nL4S43G1EN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBH","IBB","LU1778281490.HKD","LU2089984988.USD","LU1839511570.USD","LU1057294990.SGD","LU0965509010.AUD","LU1934455194.USD","MEDI","BK4550","LU0965508806.USD","BK4578","SG9999015986.USD","LU1585245621.USD","LU1430594728.SGD","LU0234570918.USD","LU1934455863.HKD","LU1571399168.USD","BK4583","BK4585","GILD","LU0965509283.SGD","BK4566","LU1934455277.USD","SG9999015978.USD","IE00BZ1G4Q59.USD","BMED","IE00BSNM7G36.USD","LU0861579265.USD","BK4588","LU1023059063.AUD","LU1674673691.USD","LU2324357040.USD","IE00BKVL7J92.USD","IBBQ","LU1061106388.HKD","IE0002270589.USD","LU0289739699.SGD","IE00B3T34201.USD","LU0320765992.SGD","LU1066053197.SGD","BK4532","LU0823416689.USD","IE00B7SZLL34.SGD","LU1037948897.HKD","BIB","LU2468319806.SGD","IE00B19Z3B42.SGD","LU2087621335.USD","LU0114720955.EUR"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":9,"totalSize":200,"code":"91000000","status":"200"}]}}